Cartherics Pty Ltd

About:

Cartherics creates immunotherapy treatments to combat cancers.

Twitter/X: cartherics

Top Investors: Medical Research Future Fund (MRFF)

Description:

Cartherics develops immunotherapy therapies to treat various malignancies. They combine immune targeting with gene editing and CAR technology to develop cell therapy and provide patients with a wider range of over-the-counter medications.

Total Funding Amount:

20.4M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Melbourne, Victoria, Australia

Founded Date:

2014-01-01

Contact Email:

info(AT)cartherics.com

Founders:

Alan Trounson, Ian Nisbet, Peter J. Hudson, Richard Boyd, Robert Moses

Number of Employees:

11-50

Last Funding Date:

2024-09-30

IPO Status:

Private

Industries: